...
首页> 外文期刊>Supportive care in cancer: official journal of the Multinational Association of Supportive Care in Cancer >Taste alteration in breast cancer patients treated with taxane chemotherapy: Experience, effect, and coping strategies
【24h】

Taste alteration in breast cancer patients treated with taxane chemotherapy: Experience, effect, and coping strategies

机译:紫杉烷类化学疗法治疗的乳腺癌患者的口味变化:经验,效果和应对策略

获取原文
获取原文并翻译 | 示例

摘要

Purpose: This study examined the experience and coping strategies for taste alteration in female breast cancer patients treated with docetaxel or paclitaxel. Methods: A purposive sample of 25 patients currently receiving docetaxel or paclitaxel or within 6 months of having completed treatment was recruited. Semi-structured interviews and patient-level data were utilized for this exploratory descriptive study. Interview data were analyzed with the constant comparative method; patient-level data were abstracted from the electronic medical record. Results: Of all side effects reported from taxanes, the most common was taste alteration (8 of 10 docetaxel patients, 3 of 15 paclitaxel patients). Women that experience taste alteration chose not to eat as much, ate on an irregular schedule, and/or lost interest in preparing meals for themselves and/or their family. Women adopted a variety of new behaviors to deal with the taste alteration and its effects, including trying new recipes, eating strongly flavored foods, honoring specific food cravings, eating candy before meals, cutting food with lemon, drinking sweetened drinks, using plastic eating utensils, drinking from a straw, brushing their teeth and tongue before meals, and using baking soda and salt wash or antibacterial mouthwash. Conclusions: Taste alteration affects breast cancer patients' lives, and they develop management strategies to deal with the effect. While some self-management strategies can be seen as positively adaptive, the potential for increased caloric consumption and poor eating behaviors associated with some coping strategies may be a cause for concern given the observation of weight gain during breast cancer treatment and association of obesity with poor treatment outcomes in breast cancer patients. Further studies are warranted to determine the overall burden of this symptom and measurement of cancer and non-cancer-related consequences of these behavioral adaptations.
机译:目的:本研究探讨了接受多西他赛或紫杉醇治疗的女性乳腺癌患者的味觉改变经验和应对策略。方法:收集25例目前接受多西他赛或紫杉醇或在完成治疗后6个月内的患者的目标样本。该探索性描述性研究使用了半结构化访谈和患者水平的数据。访谈数据采用常数比较法进行分析;从电子病历中提取患者水平的数据。结果:在紫杉烷类药物报告的所有副作用中,最常见的是味觉改变(10多西紫杉醇患者中有8个,15个紫杉醇患者中有3个)。经历口味改变的女性选择不进食过多,不定期进餐和/或失去为自己和/或家人准备饭菜的兴趣。妇女采取了多种新行为来应对口味改变及其影响,包括尝试新食谱,进食浓味食品,满足特定的食物渴望,饭前吃糖果,加柠檬切食物,喝甜饮料,使用塑料餐具,用吸管喝水,饭前刷牙和舌头,并使用小苏打和盐洗或抗菌漱口水。结论:味觉改变影响乳腺癌患者的生活,他们制定了应对策略来应对这种影响。虽然一些自我管理策略可以被认为是积极适应性的,但鉴于在乳腺癌治疗期间观察到体重增加以及肥胖与贫困人群之间的关系,与某些应对策略相关的热量消耗增加和进食行为不良的潜力可能会引起关注。乳腺癌患者的治疗结局。有必要进行进一步的研究来确定这种症状的总体负担,并测量癌症以及这些行为适应措施与癌症无关的后果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号